FDA Inspection 1240993 — Nicholas Alexander Vitanza, M.D
The FDA completed an inspection of Nicholas Alexander Vitanza, M.D on Apr 4, 2024 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Apr 4, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Seattle, WA (United States)
Additional Details
Clinical Investigator (CI)